News
Published 02/21/2012 - 9:46 a.m. CST
|
The U.S. Food and Drug
Administration today
announced a series of
steps to increase the
supply of critically
needed cancer drugs and
build on President
Obama’s Executive Order
to help prevent future
drug shortages.
“A drug shortage can be a frightening prospect for patients and President Obama made it clear that preventing these shortages from happening is a top priority of his administration,” said FDA Commissioner Margaret A. Hamburg, M.D. “Through the collaborative work of FDA, industry, and other stakeholders, patients and families waiting for these products or anxious about their availability should now be able to get the medication they need.”
“A drug shortage can be a frightening prospect for patients and President Obama made it clear that preventing these shortages from happening is a top priority of his administration,” said FDA Commissioner Margaret A. Hamburg, M.D. “Through the collaborative work of FDA, industry, and other stakeholders, patients and families waiting for these products or anxious about their availability should now be able to get the medication they need.”
Published 02/21/2012 - 6:49 a.m. CST
Study shows resilient
cells lengthen telomeres
by other means;
identifies targets to
defeat effect
HOUSTON — Inhibiting telomerase, an enzyme that rescues malignant cells from destruction by extending the protective caps on the ends of chromosomes, kills tumor cells but also triggers resistance pathways that allow cancer to survive and spread, scientists report in the Feb. 17 issue of Cell.
"Telomerase is overexpressed in many advanced cancers, but assessing its potential as a therapeutic target requires us to understand what it does and how it does it," said senior author Ronald DePinho, M.D., president of The University of Texas MD Anderson Cancer Center.
HOUSTON — Inhibiting telomerase, an enzyme that rescues malignant cells from destruction by extending the protective caps on the ends of chromosomes, kills tumor cells but also triggers resistance pathways that allow cancer to survive and spread, scientists report in the Feb. 17 issue of Cell.
"Telomerase is overexpressed in many advanced cancers, but assessing its potential as a therapeutic target requires us to understand what it does and how it does it," said senior author Ronald DePinho, M.D., president of The University of Texas MD Anderson Cancer Center.
Published 02/20/2012 - 9:42 a.m. CST
|
HOUSTON, TX – Cy-Fair
Emergency & Imaging
Center has been awarded a
three-year term of
accreditation in computed
tomography (CT) by the
American College of
Radiology (ACR). The ACR
is the largest and oldest
imaging accrediting body
in the United States and
a professional
organization of 34,000
physicians. The
organization’s gold seal
of accreditation
represents the highest
level of image quality
and patient
safety.
CT is a noninvasive medical test that helps physicians diagnose and tailor treatments for various medical conditions. To earn ACR accreditation, the center voluntarily went through a vigorous review process and met specific requirements for personnel qualifications, equipment standards, quality assurance, and quality control procedures.
CT is a noninvasive medical test that helps physicians diagnose and tailor treatments for various medical conditions. To earn ACR accreditation, the center voluntarily went through a vigorous review process and met specific requirements for personnel qualifications, equipment standards, quality assurance, and quality control procedures.
Published 02/20/2012 - 6:44 a.m. CST
|
McNeil Consumer Healthcare is recalling Infants’ Tylenol Oral Suspension in the 1 oz grape-flavored version after consumer complaints about its dosing system.
Seven lots, or about 574,000 bottles of the product, are being recalled at the wholesale and retail levels nationwide.
The product’s SimpleMeasure dosing system includes a dosing syringe that a parent or caregiver inserts into a protective cover, or flow restrictor, at the top of the bottle to measure the proper dose. In some cases, the flow restrictor was pushed into the bottle while consumers were inserting the syringe.
Lot numbers of the recalled products are as follows: BIL0U00, BIL0V00, BIL3500, BJL2D00, BJL2E00, BJL2T00, BJL2U00. The UPC code is 300450122308.
Local Weather Forecast
Get your local weather
Fox News
ESPN Sports Headlines
Our Newest Articles
ESPN Sports Headlines
Copyright 2011 TheCypressTimes . All Rights Reserved.
V422
